Sunitinib or Sorafenib as Neoadjuvant Therapy May not Improve the Survival Outcomes of Renal Cell Carcinoma with Tumor Thrombus (Q91299466)
Jump to navigation
Jump to search
scientific article published on 05 September 2018
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Sunitinib or Sorafenib as Neoadjuvant Therapy May not Improve the Survival Outcomes of Renal Cell Carcinoma with Tumor Thrombus |
scientific article published on 05 September 2018 |
Statements
Sunitinib or Sorafenib as Neoadjuvant Therapy May not Improve the Survival Outcomes of Renal Cell Carcinoma with Tumor Thrombus (English)
Wen Cai
Jiwei Huang
Yichu Yuan
Xiaoyi Hu
Mingyang Li
Wen Kong
Jin Zhang
Jianming Guo
Yonghui Chen